Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients

Clinical Cancer Research

Volumn 3, Issue 11, 1997, Pages 1923-1930

  Mieke, W ^a   Mulder, C ^a   Stern, Peter L ^b   Stukart, Marij J ^a   De Windt, Evelien ^a   Butzelaar, Rudolf M J M ^c   Meijer, Sybren ^a   Adèr, Henk J ^d   Claessen, Anke M E ^a   Vermorken, Jan B ^a   Meijer, Chris J L M ^a   Wagstaff, John ^a   Scheper, Rik J ^a   Bloemena, Elisabeth ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN 5T4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

AGED; ANTIGENS, CD58; ANTIGENS, NEOPLASM; BLOOD TRANSFUSION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MEMBRANE GLYCOPROTEINS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TIME FACTORS;

EID: 0030687865     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Haller, D. G. An overview of adjuvant therapy for colorectal cancer. Eur. J. Cancer, 31A: 1255-1263, 1995.
2. Hole, N., and Stern, P. L. Isolation and characterization of 5T4, a tumour-associated antigen. Int. J. Cancer, 45: 179-184, 1990.
3. Southall, P. J., Boxer, G. M., Bagshawe, K. D., Hole, N., Bromley, M., and Stern, P. L. Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br. J. Cancer, 61: 89-95, 1990.
4. Carsberg, J. L., Myers, K. A., Evans, G. S., Allen, T. D., and Stern, P. L. Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. J. Cell Sci., 108: 2905-2916, 1995.
5. Starzynska, T., Rahi, V., and Stern, P. L. The expression of 5T4 antigen in colorectal and gastric carcinoma. Br. J. Cancer, 66: 867-869, 1992.
6. Starzynska, T., Marsh, P. J., Schofield, P. F., Roberts, S. A., Myers, K. A., and Stern, P. L. Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. Br. J. Cancer, 69: 899-902, 1994.
7. Hoover, H. C., Jr., Brandhorst, J. S., Peters, L. C., Surdyke, M. G., Takeshita, Y., Madariaga, J., Muenz, L. R., and Hanna, M. G., Jr. Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a Phase III prospectively randomized trial. J. Clin. Oncol., 11: 390-399, 1993.
8. Johnson, J. G., and Jenkins, M. K. Accessory cell-derived signals required for T cell activation. Immunol. Res., 12: 48-64, 1993.
9. Cordon-Cardo, C., Fuks, Z., Drobnjak, M., Moreno, C., Eisenbach, L., and Feldman, M. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res., 51: 6372-6380, 1991.
10. Smith, M. E. F., Marsh, S. G. E., Bodmer, J. G., Gelsthorpe, K., and Bodmer, W. F. Loss of HLA-A, B, C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc. Natl. Acad. Sci. USA, 86: 5557-5561, 1989.
11. Daar, A. S., and Fabre, J. W. The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR. Eur. J. Cancer Clin. Oncol., 19: 209-220, 1983.
12. Durrant, L. G., Ballentyne, K. C., Armitage, N. C., Robins, R. A., Marksman, R., Hardcastle, J. D., and Baldwin, R. W. Quantitation of MHC antigen expression on colorectal tumors and its association with tumor progression. Br. J. Cancer, 56: 425-432, 1987.
13. Dippold, W., Wittig, B., Schwaeble, W., Mayet, W., and Meyer zum Büschenfelde, K-H. Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. Gut, 34: 1593-1597, 1993.
14. Kelly, C. P., O'Keane, J. C., Orellana, J., Schroy, P. C., Yang, S., LaMont, J. T., and Brady, H. R. Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am. J. Physiol., 263: G864-G870, 1992.
15. Ransom, J. H., Pelle, B., and Hanna, M. G., Jr. Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy. Cancer Res., 52: 3460-3466, 1992.
16. Bloemena, E., Gall, H., Ransom, J. H., Pomato, N., Murray, J. H., Bos, E., Scheper, R. J., Meijer, C. J. L. M., Hanna, M. G., Jr, and Vermorken, J. B. Delayed-type hypersensitivity reactions to tumor-associated antigens in colon carcinoma patients immunized with an autologous tumor cell/Bacillus Calmette-Guérin vaccine. Cancer Res., 53: 1-4, 1993.
17. Astler, V. B., and Coller, F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg., 139: 846-851, 1954.
18. Houbiers, J. G. A., Brand, A., Van de Watering, L. M. G., Hermans, J., Verweij, P. J. M., Bijnen, A. B., Pahlplatz, P., Eeftinck Schattenkerk, M., Wobbes, T., De Vries, J. E., Klementschitsch, P., Van de Maas, A. H. M., and Van de Velde, C. J. H. Randomised controlled trial comparing transfusion of leucocyte-depleted of buffy-coat-depleted blood in surgery for colorectal cancer. Lancet, 344: 573-578, 1994.
19. Gerdts, B., von Meyenfeldt, M. F., Meijerink, J., De Bruijne, A. P., Arends, J. S., and Wiggers, T. Ten-year follow-up after operation for cancer of the colon: no more deaths from tumour after seven years (English abstract). Ned. Tijdschr. G, 139: 382-388, 1995.
20. Stam, N. J., Vroom, T. M., Peters, P. J., Pastoors, E. B., and Ploegh, H. L. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int. Immunol., 2: 113-125, 1990.
21. Sánchez-Madrid F., Krensky, A. M., Ware, C. F., Robbins, E., Strominger, J. L., Burakoff, S. J., and Springer, T. A. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2 and LFA-3. Proc. Natl. Acad. Sci. USA, 79: 7489-7493, 1982.
22. Rothlein, R., Dustin, M. L., Marlin, S. D., and Springer, T. A. A human intercellular adhesion molecules (ICAM-1) distinct from LFA-1. J. Immunol., 137: 1270-1274, 1986.
23. Hole, N., and Stern, P. L. A 72kD trophoblast glycoprotein defined by a monoclonal antibody. Br. J. Cancer, 57: 239-246, 1988.
24. Mulder, W. M. C., Koenen, H., van de Muysenberg, A. J. C., Bloemena, E., Wagstaff, J., and Scheper, R. J. Reduced expression of distinct T-cell molecules by collagenase/DNase treatment. Cancer Immunol. Immunother., 38: 253-258, 1994.
25. Wielenga, V. J. M., Heider, K-H., Offerhaus, G. J. A., Adolf, G. R., Van den Berg, F. M., Ponta, H., Herrlich, P., and Pals, S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53: 4754-4756, 1993.
26. Oppenheimer-Marks, N., Davis, L. S., Tompkins Bogue, D., Ramberg, J., and Lipsky, P. E. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J. Immunol., 147: 2913-2921, 1991.
27. Picker, I. J., Treer, J. E., Nguyen, M., Terstappen, L. W., Hogg, N., and Yednock, T. Coordinate expression of β1 and β2 integrin "activation" epitopes during T cell responses in secondary lymphoid tissue. Eur. J. Immunol., 23: 2751-2757, 1993.
28. Dougherty, G. J., Murdoch, N. H., and Hogg, N. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur. J. Immunol., 18: 35-39, 1988.
29. Vánky, F., Wang, P., Patarroyo, M., and Klein, E. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol. Immunother., 31: 19-27, 1990.
30. Katsanis, E., Bausero, M. A., Xu, H., Orchard, P. J., Xu, Z., McIvor, R. S., Brian, A. A., and Blazar, B. R. Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis reduces in vivo tumorigenicity and decreases ICAM-2-dependent killing. Cancer Immunol. Immunother., 38: 135-141, 1994.
31. Takahasi, T., Ishikura, H., Iwai, K., Takahashi, C., Kato, H., Tanabe, T., and Yoshiki, T. Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro. Cancer Immunol. Immunother., 36: 76-82, 1993.
32. Möller, P., Koretz, K., Schlag, P., and Momburg, F. Frequency of abnormal expression of HLA-A, B, C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence. Int. J. Cancer, 6 (Suppl.): 155-162, 1991.
33. Végh, Z., Wang, P., Vánky, F., and Klein, E. Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors. Cancer Res., 53: 2416-2420, 1993.
34. Momburg, F., Ziegler, A., Harpprecht, J., Möller, P., Moldenhauer, G., and Hämmerling, G. J. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J. Immunol., 142: 352-358, 1989.
35. Kaklamanis, L., Townsend, A., Doussis-Anagnostopoulou, I. A., Mortensen, N., Harris, A. L., and Gatter, K. C. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am. J. Pathol., 145: 505-509, 1994.
36. x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res., 53: 3632-3637, 1993.
37. a as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer (Phila.), 75: 2051-2056, 1995.
38. Itzkowitz, S. H., Bloom, E. J., Kokal, W. A., Modin, G., Hakomori. S., and Kim, Y. S. Sialosyl-Tn: a novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer (Phila.), 66: 1960-1966, 1990.
39. Hamelin, R., Laurent-Puig, P., Olschwang, S., Jego, N., Asselain, B., Remvikos, Y., Girodet, J., Soalmon, R. J., and Thomas, G. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology, 106: 42-48, 1994.